AU2009268549B2 - Cyclosporin derivatives for treating ocular and dermal diseases and conditions - Google Patents

Cyclosporin derivatives for treating ocular and dermal diseases and conditions Download PDF

Info

Publication number
AU2009268549B2
AU2009268549B2 AU2009268549A AU2009268549A AU2009268549B2 AU 2009268549 B2 AU2009268549 B2 AU 2009268549B2 AU 2009268549 A AU2009268549 A AU 2009268549A AU 2009268549 A AU2009268549 A AU 2009268549A AU 2009268549 B2 AU2009268549 B2 AU 2009268549B2
Authority
AU
Australia
Prior art keywords
group
cyclosporin
alk
derivative
rio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2009268549A
Other languages
English (en)
Other versions
AU2009268549A1 (en
Inventor
Michael E. Garst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2009268549A1 publication Critical patent/AU2009268549A1/en
Application granted granted Critical
Publication of AU2009268549B2 publication Critical patent/AU2009268549B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
AU2009268549A 2008-07-10 2009-07-09 Cyclosporin derivatives for treating ocular and dermal diseases and conditions Expired - Fee Related AU2009268549B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13451008P 2008-07-10 2008-07-10
US61/134,510 2008-07-10
PCT/US2009/050038 WO2010006117A2 (fr) 2008-07-10 2009-07-09 Dérivés de cyclosporine pour traiter des maladies et états oculaires et dermiques

Publications (2)

Publication Number Publication Date
AU2009268549A1 AU2009268549A1 (en) 2010-01-14
AU2009268549B2 true AU2009268549B2 (en) 2015-07-16

Family

ID=41404608

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009268549A Expired - Fee Related AU2009268549B2 (en) 2008-07-10 2009-07-09 Cyclosporin derivatives for treating ocular and dermal diseases and conditions

Country Status (10)

Country Link
US (2) US8716238B2 (fr)
EP (1) EP2313157A2 (fr)
JP (1) JP5661035B2 (fr)
KR (1) KR20110031973A (fr)
CN (1) CN102149402B (fr)
AU (1) AU2009268549B2 (fr)
BR (1) BRPI0915552A2 (fr)
CA (1) CA2730108A1 (fr)
RU (2) RU2521358C2 (fr)
WO (1) WO2010006117A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006117A2 (fr) * 2008-07-10 2010-01-14 Allergan, Inc. Dérivés de cyclosporine pour traiter des maladies et états oculaires et dermiques
WO2010138422A1 (fr) * 2009-05-27 2010-12-02 Allergan, Inc. Dérivés de cyclosporine pour améliorer la pousse des cheveux
AU2010254316A1 (en) * 2009-05-27 2011-12-22 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
US9175042B2 (en) 2010-10-12 2015-11-03 Allergan, Inc. Cyclosporin analogs
JP5805774B2 (ja) 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンアナログ
WO2012079172A1 (fr) * 2010-12-15 2012-06-21 Isotechnika Pharma Inc. Molécules analogues de cyclosporine modifiées au niveau des acides aminés 1 et 3
ES2675269T3 (es) * 2011-11-15 2018-07-10 Allergan, Inc. Suspensiones tratables en autoclave de ciclosporina A de forma 2
AU2013267435B2 (en) 2012-06-01 2017-11-09 Allergan, Inc. Cyclosporin A analogs
WO2014138437A1 (fr) 2013-03-08 2014-09-12 Allergan, Inc. Conjugués de stéroïdes
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
CN113144203A (zh) 2015-09-28 2021-07-23 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
CA3019349A1 (fr) 2016-04-14 2017-10-19 Azura Ophthalmics Ltd. Compositions de disulfure de selenium destinees a etre utilisees dans le traitement du dysfonctionnement de la glande de meibomius
EP4087655A4 (fr) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd Instructions pour composition et sensibilité

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061168A1 (fr) * 1999-04-13 2000-10-19 Allergan Sales, Inc. Traitement oculaire utilisant des derives de cyclosporine-a

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FR2757522B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757521B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
KR20010052766A (ko) 1998-06-12 2001-06-25 침머만 다니엘 신규한 사이클로스포린
US6806279B2 (en) 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
WO2010006117A2 (fr) * 2008-07-10 2010-01-14 Allergan, Inc. Dérivés de cyclosporine pour traiter des maladies et états oculaires et dermiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061168A1 (fr) * 1999-04-13 2000-10-19 Allergan Sales, Inc. Traitement oculaire utilisant des derives de cyclosporine-a

Also Published As

Publication number Publication date
BRPI0915552A2 (pt) 2017-06-20
WO2010006117A3 (fr) 2010-03-04
AU2009268549A1 (en) 2010-01-14
CN102149402A (zh) 2011-08-10
WO2010006117A2 (fr) 2010-01-14
JP2011527694A (ja) 2011-11-04
US20100009953A1 (en) 2010-01-14
US8716238B2 (en) 2014-05-06
JP5661035B2 (ja) 2015-01-28
CA2730108A1 (fr) 2010-01-14
RU2011104584A (ru) 2012-08-20
EP2313157A2 (fr) 2011-04-27
CN102149402B (zh) 2014-07-09
US20140200185A1 (en) 2014-07-17
RU2521358C2 (ru) 2014-06-27
RU2014101057A (ru) 2015-07-20
KR20110031973A (ko) 2011-03-29

Similar Documents

Publication Publication Date Title
AU2009268549B2 (en) Cyclosporin derivatives for treating ocular and dermal diseases and conditions
AU759753B2 (en) Ocular treatment using cyclosporin-A derivatives
AU2012262513B2 (en) A crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
US9266927B2 (en) Cyclosporin A analogs
WO2007136759A2 (fr) Procédé de traitement et de prévention de troubles oculaires
US8524671B2 (en) Cyclosporin derivatives for treating inflammatory diseases and conditions

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee